The Sanofi Foundation is opening a new chapter with a strengthened commitment to children and young people, particularly those living with serious diseases. Through the Foundation, Sanofi extends its commitment to improving people's lives beyond healthcare by supporting younger generations facing some of today's most pressing health, climate, and humanitarian challenges.

Central nervous system arteriovenous malformations, or CNS-AVMs, are abnormal tangles of blood vessels in the brain or spinal cord. They form direct high-flow connections between arteries and veins and can cause hemorrhagic stroke, seizures, headache, neurological deficits, or progressive disability, especially in children and young adults. Current treatments, including microsurgery, embolization, and stereotactic radiosurgery, can be effective but are invasive and may carry substantial risks for patients with complex lesions.

Researchers at the University of Houston’s College of Pharmacy have discovered an unexpected simple strategy to improve the performance of mRNA vaccines and gene therapeutics: adding salt. The findings, published in Small, address one of the biggest challenges facing modern gene medicine - getting fragile therapeutic material to the right place inside cells.

Immutep Aces Phase IIb in First-Line Head and Neck Cancer, Eyes Regulatory Path Ahead 7/12/2024

Senate Unanimously Passes Bill to Reduce Big Pharma Patent Thickets, Increase Competition 7/12/2024

AbbVie’s Humira Continues to Lose Market Share as Biosimilars Gain Ground: Report 7/12/2024

Akebia Ends Deal With CSL Vifor, Unveils Hefty Price Tag for CKD Anemia Drug Vafseo 7/12/2024

PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices 7/12/2024

Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff 7/12/2024

FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected 7/12/2024

EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm 4/12/2024

EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail 4/12/2024

AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates 4/12/2024

Enlivex’s Stock Plummets 50% on Phase II Sepsis Results for Cell Therapy 4/12/2024

Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy 4/12/2024

AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma 4/12/2024

Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031 4/12/2024

Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR 4/12/2024

CryoEM: Evolution and Best Practices 4/12/2024

Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This Year 7/11/2024